Multiple Sclerosis

Latest News

Traffic Light System-Based Education Helps Physicians With Decision-Making

Publish Date January 20, 2021

Researchers sought to determine whether educational intervention can decrease therapeutic inertia by reducing autonomic arousal response (pupil dilation), a proxy measurement of how physicians respond to uncertainty during clinical decisions.

Optic Nerve Data Helps Boost Diagnostic Performance Among Patients With MS

Publish Date January 14, 2021

Investigators evaluated the added value of incorporating data on the optic nerve region to current diagnostic criteria for patients with multiple sclerosis.

Predictive Markers of First-Line Treatment Failure in Patients with MS

Publish Date January 12, 2021

Study researchers found several clinical and imaging factors that predicted first-line treatment failure in patients with recently diagnosed relapsing remitting MS.

Wearable Biosensors Can Quantify, Monitor MS in Clinic and Free-Living Settings

Publish Date January 11, 2021

Researchers evaluated the viability and correlation of wearable biosensors with traditional clinical measures of disability in patients with MS.

The Effects of Cognitive and Brain Reserve on Social Cognition in MS

Publish Date January 7, 2021

Study researchers investigated the effects of cognitive reserve and brain reserve on social cognition in patients with Multiple Sclerosis.

Effect of Siponimod on Cognition in MS Patients Explored

Publish Date January 6, 2021

Mixed results seen for effect of siponimod on cognitive processing speed in patients with secondary progressive multiple sclerosis

Electronic Patient-Reported EDSS Highly Correlates With Standard EDSS for Disability Assessment in MS

Publish Date January 5, 2021

An electronic, unsupervised, patient-reported EDSS to assess disability in multiple sclerosis offers promise in clinical research and care for this population.

Demyelinating Plaque Represents Cause of Trigeminal Neuralgia Secondary to MS

Publish Date December 29, 2020

Study researchers investigated whether neurovascular contact with morphological changes influences the etiology of trigeminal neuralgia secondary to MS.

FDA Approves Shorter Infusion Time for MS Drug Ocrevus

Publish Date December 16, 2020

The approval was based on data from the phase 3b ENSEMBLE PLUS study that compared the frequency and severity of infusion-related reactions for a 2-hour Ocrevus infusion time to the previously approved 3.5-hour infusion time in patients with relapsing-remitting MS.

Improvements in Depression Linked to Improvements in Fatigue, Pain in MS

Publish Date December 14, 2020

Reducing depressive symptoms early may result in better improvements in fatigue and pain interference in patients with multiple sclerosis.